Herbal medicinal products are widely used, vary greatly in content and quality, and are actively tested in randomized, controlled trials (RCTs).  The authors' objective was to develop recommendations for reporting RCTs of herbal medicine interventions, based on the need to elaborate on the 22-item Consolidated Standards of Reporting Trials (CONSORT) checklist.

Telephone calls were made and a consensus meeting was held with 16 participants in Toronto, Canada, to develop these recommendations.  The group agreed on context-specific elaborations of nine CONSORT checklist items for RCTs of herbal medicines.  Item four, concerning the herbal medicine intervention, required the most extensive elaboration.  These recommendations have been developed to improve the reporting of RCTs using herbal medicine interventions.